Article

Fundus camera gets 510(k) clearance

Optovue has received 510(k) clearance for the iCam Non-Mydriatic compact fundus camera, which produces 45° color fundus images of the eye as well as external ocular structures.

 

Fremont, CA- Optovue has received 510(k) clearance for the iCam Non-Mydriatic compact fundus camera. The iCam camera produces 45° color fundus images of the eye as well as external ocular structures.

The iCam includes a variety of functions and features that produce high-quality image documentation and management of ocular health. A 12-bit CCD sensor is used to provide deep, rich colors with lower noise than typical 8-bit CMOS sensors used in competing cameras. An LED light source is used for reduced peak light energy to the eye as well as longer life.

“In our clinic, we believe that the clearance of [the camera] is a game changer, as it gives any clinician the opportunity to do high-quality, easy-to-use fundus photography of various pathologies,” said Jorge Cuadros, OD, of Buena Vista Eyecare Group, San Jose, CA. “In addition, it has an economical pricing structure and unparalleled imaging capabilities with a learning curve that is minimal compared [with] that of other devices.”

Optovue expects to release the iCam to the United States market early in the second quarter, followed by a global release.

 

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.